Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Publications of the Health Environment & Infection Research Unit (HEIRU)

Puka rangahau

The following section lists selected publications of HEIRU Staff members organised into broad topic areas.

Infectious disease burden and inequalities

  • Baker MG, Barnard LT, Kvalsvig A, Verrall A, Zhang J, Keall M, Wilson N, Wall T, Howden-Chapman P. Increasing incidence of serious infectious diseases and inequalities in New Zealand: a national epidemiological study. Lancet 2012. [Abstract]
  • Wilson N, Howden-Chapman P, Baker MG. Comparing Finland with New Zealand: lessons from Finland for controlling infectious diseases. N Z Med J 2012; 125(1353):156-158.
  • Chambers S, Baker M. Infectious diseases – far from defeated. NZ Med J 2004; 117(1200). U1013.

Rheumatic fever and Streptococcal diseases

  • Cannon JW, Jack S, Wu Y, Zhang J, Baker MG, Geelhoed E, Fraser J, Carapetis JR. An economic case for a vaccine to prevent group A streptococcus skin infections. Vaccine, 2018; 36: 6968-78. doi: 10.1016/j.vaccine.2018.10.001
  • Oliver J, Pierse N, Williamson DA, Baker MG. Estimating the likely true changes in rheumatic fever incidence using two data sources. Epidemiology and Infection. 2018;146(2):265-75.
  • Oliver J, Malliya Wadu E, Pierse N, Moreland NJ, Williamson DA, Baker MG. Group A Streptococcus pharyngitis and pharyngeal carriage: A meta-analysis. PLoS neglected tropical diseases. 2018 Mar;12(3):e0006335. PubMed PMID: 29554121. Pubmed Central PMCID: 5875889.
  • Oliver J, Foster T, Williamson DA, Pierse N, Baker MG. Using preceding hospital admissions to identify children at risk of developing acute rheumatic fever. J Paediatr Child Health. 2018 May;54: 499-505. PubMed PMID: 29168244.
  • Oliver J, Foster T, Kvalsvig A, Williamson DA, Baker MG, Pierse N. Risk of rehospitalisation and death for vulnerable New Zealand children. Arch Dis Child. 2018; 103: 327-34. PubMed PMID: 28735258.
  • Jack SJ, Williamson DA, Galloway Y, Pierse N, Zhang J, Oliver J, Milne RJ, Mackereth G, Jackson CM, Steer AC, Carapetis JR, Baker MG. Primary prevention of rheumatic fever in the 21st century: evaluation of a national programme. Int J Epidemiol. 2018 Jul 27. PubMed PMID: 30060070.
  • Doyle H, Pierse N, Tiatia R, Williamson D, Baker MG, Crane J. The effect of the oral probiotic Streptococcus salivarius (K12) on Group A streptococcus pharyngitis: a pragmatic trial in schools. Pediatr Infect Dis J. 2017 Nov 15. doi: 10.1097/INF.0000000000001847.[Epub ahead of print].
  • Oliver JR, Pierse N, Stefanogiannis N, Jackson C, Baker MG. Acute rheumatic fever and exposure to poor housing conditions in New Zealand: A descriptive study. J Paediatrics Child Health. 2017, 53:358-64.
  • Gurney JK, Stanley J, Baker MG, Wilson NJ, Sarfati D. Estimating the risk of acute rheumatic fever in New Zealand by age, ethnicity and deprivation" in its current form for publication in Epidemiology and Infection. Epidemiol Infect 2016 Jun 17:1-0.
  • Jack S, Williamson D, Baker MG, Galloway Y, Pierse N, Milne R, Mackereth G, Zhang J, Oliver J. Interim Evaluation of the Sore Throat Component of the Rheumatic Fever Prevention Programme – Quantitative Findings. The Institute of Environmental Science and Research Ltd. Porirua, New Zealand; 2015
  • Williamson DA, Smeesters PR, Steer AC, Steemson JD, Ng AC, Proft T, Fraser JD, Baker MG, Morgan J, Carter PE, Moreland NJ. M-protein analysis of Streptococcus pyogenes isolates associated with acute rheumatic fever in New Zealand. J Clin Micro. 2015 Nov 1;53(11):3618-20.
  • Williamson DA, Morgan J, Fraser JD, Moreland NJ, Proft T, Mackereth G, Lennon D, Baker MG, Carter PE. Increasing incidence of invasive group A streptococcus disease in New Zealand, 2002 – 2012: A national population-based study. J Infect 2015;70:127-34.
  • Oliver J, Baker MG, Pierse N, Carapetis J. Comparison of approaches to rheumatic fever surveillance across Organisation for Economic Co‐operation and Development countries. Journal of paediatrics and child health. 2015 Nov 1;51(11):1071-7.
  • Oliver J, Pierse N, Baker MG. Estimating rheumatic fever incidence in New Zealand using multiple data sources. Epidemiol Infect 2015; 143: 167-177.
  • Moreland NJ, Waddington CS, Williamson DA, Sriskandan S, Smeesters PR, Proft T, Steer AC, Walker MJ, Baker EN, Baker MG, Lennon D, Dunbar R, Carapetis J, Fraser JD. Working towards a Group A Streptococcal vaccine: Report of a collaborative Trans-Tasman workshop. Vaccine 2014.
  • Oliver J, Pierse N, Baker MG. Improving rheumatic fever surveillance in New Zealand: Results of a surveillance sector review. BMC Public Health 2014, 14: 528.
  • Williamson DA, Moreland NJ, Carter P, Upton A, Morgan J, Proft T, Lennon D, Baker MG, Dunbar R, Fraser JD. Molecular epidemiology of group A streptococcus from pharyngeal isolates in Auckland. NZ Med J 2013, 127: 55-60.
  • Jaine R, Baker M, Venugopal K. Acute rheumatic fever associated with household crowding in a developed country. Pediatr Infect Dis J 2011; 30: 315-9.
  • Jaine R, Baker M, Venugopal K. Epidemiology of acute rheumatic fever in New Zealand 1996-2005. Paediatrics and child health 2008;44:564-71.

Skin & soft tissues infections

  • Williamson DA, Ritchie SR, Roberts SA, Coombs GW, Thomas MG, Hannaford O, Baker MG, Lennon D, Fraser JD. Clinical and molecular epidemiology of community-onset invasive Staphylococcus aureus infection in New Zealand children. Epidemiol Infect 2014: 1-9.
  • Williamson DA, Zhang J, Ritchie SR, Roberts SA, Fraser JD, Baker MG. Staphylococcus aureus Infections in New Zealand, 2000-2011. Emerg Infect Dis. 2014 Jul;20(7):1157-62
  • Williamson DA, Lim A, Thomas MG, Baker MG, Roberts SA, Fraser JD, Ritchie SR. Incidence, trends and demographics of Staphylococcus aureus infections in Auckland, New Zealand, 2001-2011. BMC Infect Dis. 2013; 13: 569. doi: 10.1186/1471-2334-13-569.
  • Williamson DA, Ritchie SR, Lennon D, Roberts SA, Stewart J Thomas MG, Baker MG. Increasing incidence and marked sociodemographic variation in community-onset Staphylococcus aureus skin and soft tissue infections in New Zealand children. Paed Infect Dis J. 2013; 32: 923-5.
  • Das DK, Baker MG, Venugopal K. Risk factors, microbiological findings and outcomes of necrotizing fasciitis in New Zealand: a retrospective chart review. BMC Infect Dis. 2012; 12: 348 doi: 10.1186/1471-2334-12-348.
  • O’Sullivan C, Baker MG. Skin infections in children in a New Zealand primary care setting: exploring beneath the tip of the iceberg. N Z Med J. 2012; 125: 70-9.
  • O’Sullivan C, Baker MG. Serious skin infections in children: a review of admissions to Gisborne Hospital (2006-2007). N Z Med J. 2012; 125: 55-69.
  • O’Sullivan C, Baker MG, Zhang J, Davies A, Cramp G. The epidemiology of serious skin infections in New Zealand children: comparing the Tairawhiti region with national trends. N Z Med J 2012; 125: 40-54.
  • Das D, Baker MG, Venugopal K. Increasing incidence of necrotizing fasciitis in New Zealand, 1990-2006. J Infect 2011; 63: 429-33. Epub 2011 Aug 16.
  • O'Sullivan CE, Baker MG, Zhang J. Increasing hospitalizations for serious skin infections in New Zealand children, 1990-2007. Epidemiol Infect 2011; 139: 1794-804 Epub 2010 Dec 15.
  • O’Sullivan C, Baker MG. A proposed epidemiological case definition for serious skin infection in children. J Paed Child Health. 2010; 46: 176-83.

Long-term effects of acute infections

  • Teng AM, Blakely T, Baker MG, Sarfati D. The contribution of Helicobacter pylori to excess gastric cancer in Indigenous and Pacific men: a birth cohort estimate. Gastric Cancer. 2017; 20: 752-5.
  • Baker MG, Kvalsvig A, Zhang J, Lake R, Sears A, Wilson N. Declining Guillain-Barré Syndrome after Campylobacteriosis Control, New Zealand, 1988–2010. Emerg Infect Dis 2012;18:226-233.
  • Wilson N, Boyd M, Nisa S, Clement C, Baker MG. Did exposure to a severe outbreak of pandemic influenza in 1918 impact on long-term survival? Epidemiol Infect 2016;144:3166-9.

Campylobacteriosis and food safety

Salmonellosis

  • Lal A, Hales S, Kirk M, Baker MG, French NP. Spatial and temporal variation in the association between temperature and salmonellosis in NZ. Aust NZ J Pub Health. 2015 Jul 1.
  • Lal A, Baker MG, French NP, Dufour M, Hales S. The Descriptive Epidemiology of Human Salmonellosis in New Zealand, 1997-2008. Epidemiol Infect. 2011 Nov 30:1-10. [Epub ahead of print]
  • Britton E, Hales S, Venugopal K, Baker MG. Positive association between ambient temperature and salmonellosis notifications in New Zealand, 1965-2006. Aust NZ J Pub Health 2010; 34: 126-9.
  • Wilson N, Baker M. A systematic review of the aetiology of salmonellosis in New Zealand. Wellington: New Zealand Food Safety Authority, 2009.
  • Baker M, Thornley C, Lopez L, Garrett N, Nicol C. A recurring salmonellosis epidemic in New Zealand linked to contact with sheep. Epidemiol Infect 2007; 135: 76-83.
  • Thornley CN, Simmons GC, Callaghan ML, Nicol CM, Baker MG, Gilmore KS, Garrett NKG. First incursion of Salmonella enterica serotype Typhimurium DT160 into New Zealand. Emerg Infect Dis 2003; 9: 493-5.

Enteric diseases

  • McDonald AM, Sarfati D, Baker MG, Blakely T. Trends in Helicobacter pylori infection among Māori, Pacific and European birth cohorts in New Zealand. Helicobacter 2015;20:139-45.
  • Jaros P, Cookson AL, Campbell DM, Besser TE, Shringi S, Mackereth GF, Lim E, Lopez L, Dufour M, Marshall JC, Baker MG, Hathaway S, Prattley DJ, French NP. A prospective case-control and molecular epidemiological study of human cases of Shiga toxin-producing Escherichia coli in New Zealand. BMC Infectious Diseases 2013, 13:450.
  • Adlam SB, Perera S, Lake RJ, Campbell DM, Williman JA, Baker MG. Acute gastrointestinal illness in New Zealand: a community study. Epidemiol Infect 2011; 139: 302-8.
  • Snel SJ, Baker MG, Venugopal K, French N, Learmonth J. A tale of two parasites: The comparative epidemiology of cryptosporidiosis and giardiasis. Epidemiol Infect. 2009;137:1641-50.
  • Snel SJ, Baker MG, Venugopal K. The epidemiology of giardiasis in New Zealand, 1997-2006. N Z Med J 2009; 122: 62-75.
  • Snel SJ, Baker MG, Venugopal K. The epidemiology of cryptosporidiosis in New Zealand, 1997-2006. N Z Med J 2009; 122: 47-61.
  • Wilson N, Baker M, Edwards R, Simmons G. Case-case analysis of enteric diseases with routine surveillance data: Potential use and example results. Epidemiol Perspect Innov 2008;5:6.
  • Wilson N, Baker M. Enhanced Sentinel Surveillance for Enteric Disease in New Zealand: The Advantages, Disadvantages and Feasible Options (Report for the NZ Food Safety Authority). Wellington, 2005.

Zoonoses and One Health

  • Mayfield HJ, Smith CS, Lowry JH, Watson CH, Baker MG, Kama M, Nilles EJ, Lau CL. Predictive risk mapping of an environmentally-driven infectious disease using spatial Bayesian networks: A case study of leptospirosis in Fiji. PLoS neglected tropical diseases. 2018 Oct 11;12(10):e0006857.
  • Grout L, Hales S, French N, Baker MG. A Review of Methods for Assessing the Environmental Health Impacts of an Agricultural System. Int J Environ Res Public Health. 2018 Jun 23;15(7). PubMed PMID: 29937499. Pubmed Central PMCID: 6069469.
  • Wilson N, McIntyre M, Blaschke P, Muellner P, Mansoor OD, Baker MG. Potential public health benefits from eradicating rats in New Zealand cities and a tentative research agenda. J Royal Society of NZ 2017 Jul 21:1-1.
  • Lal A, Dobbins T, Bagheri N, Baker MG, French NP, Hales S. Cryptosporidiosis Risk in New Zealand Children Under 5 Years Old is Greatest in Areas with High Dairy Cattle Densities. EcoHealth. 2016 Dec 1;13(4):652-60.
  • Lal A, Lill AW, Mcintyre M, Hales S, Baker MG, French NP. Environmental change and enteric zoonoses in New Zealand: a systematic review of the evidence. Aust NZ J Public Health. 2015;39:63-8.
  • Wilson N, Lush D, Bell P, Wyber R. Lessons for zoonotic disease and vector eradication in New Zealand from past successes (Abstract of Conference Poster: P1-370). J Epidemiol Community Health 2011;65:A169-A170 [Abstract].
  • Zheng T, Adlam B, Rawdon T, Stanislawek WL, Cork SC, Hope V, Buddle BM, Grimwood K, Baker MG, O’Keefe JS, Huang S. A cross-sectional survey of influenza A infection and management practices in small rural backyard poultry flocks in New Zealand. N Z Vet J. 2010; 58: 74-80.
  • Baker MG, Lopez LD, Cannon MC, de Lisle GW, Collin DM. Continuing Mycobacterium bovis transmission from animals to humans in New Zealand. Epidemiol Infect 2006; 134: 1068-73.
  • Thornley CN, Baker MG, Weinstein P, Maas E. Changing epidemiology of human leptospirosis in New Zealand. Epidemiol Infect 2002; 128: 29-36.

Emerging Infectious diseases and preparedness

  • Macintyre CR, Heslop DJ, Nand D, Schramm C, Butel M, Rawlinson W, Baker MG, Kiedrzynski T, Nelson C, Rosewell A, Fotualii L, Yeo K, Elsgaard J, Fonua L, Lane JM. Exercise Mataika: White Paper on response to a smallpox bioterrorism release in the Pacific. Global Biosecurity, 2019; 1(1).
  • Scott J, Wilson N, Baker MG. Improving New Zealand's preparations for the next pandemic. Australian and New Zealand Journal of Public Health. 2018;42(1):3-6.

Influenza (pandemic & seasonal)   

  • Prasad N, Huang QS, Wood T, Aminisani N, McArthur C, Baker MG, Seeds R, Thompson MG, Widdowson M, Newbern EC. Influenza associated outcomes among pregnant, post-partum, and non-pregnant women of reproductive age. Journal of Infectious Diseases 2019. Advance online publication. doi: 10.1093/infdis/jiz035
  • Wong SS, Oshansky CM, Guo XZJ, Ralston J, Wood T, Seeds R, Newbern C, Waite B, Reynolds G, Widdowson MA, Huang QS, Webby RJ, Thomas PG, Turner N, Baker M, Grant C, McArthur C, Roberts S, Trenholmes A, Wong C, Taylor S, Thompson M, Gross D, Duque J, Haven K, Aley D, Muponisi P, Chand B, Chen Y, Plewes L, Sawtell F, Lawrence S, Cogcoy R, Smith J, Gravidez F, Ma M, Chamberlin S, Davey K, Knowles T, McLeish JA, Todd A, Bocacao J, Gunn W, Kawakami P, Walker S, Madge R, Moore N, Rahnama F, Qiao H, Tse F, Zibaei M, Korrapadu T, Optland L, Cruz CD. Severe Influenza Is Characterized by Prolonged Immune Activation: Results from the SHIVERS Cohort Study. Journal of Infectious Diseases. 2018;217(2):245-56.
  • Thompson MG, Pierse N, Sue Huang Q, Prasad N, Duque J, Claire Newbern E, Baker MG, Turner N, McArthur C, team Si. Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015. Vaccine. 2018 Sep 18;36(39):5916-25. PubMed PMID: 30077480.
  • Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Cohen C, Gran JM, Schanzer D, Cowling BJ, Wu P, Kyncl J, Ang LW, Park M, Redlberger-Fritz M, Yu H, Espenhain L, Krishnan A, Emukule G, van Asten L, Pereira da Silva S, Aungkulanon S, Buchholz U, Widdowson MA, Bresee JS, Azziz-Baumgartner E, Cheng PY, Dawood F, Foppa I, Olsen S, Haber M, Jeffers C, MacIntyre CR, Newall AT, Wood JG, Kundi M, Popow-Kraupp T, Ahmed M, Rahman M, Marinho F, Sotomayor Proschle CV, Vergara Mallegas N, Luzhao F, Sa L, Barbosa-Ramírez J, Sanchez DM, Gomez LA, Vargas XB, Acosta Herrera A, Llanés MJ, Fischer TK, Krause TG, Mølbak K, Nielsen J, Trebbien R, Bruno A, Ojeda J, Ramos H, an der Heiden M, del Carmen Castillo Signor L, Serrano CE, Bhardwaj R, Chadha M, Narayan V, Kosen S, Bromberg M, Glatman-Freedman A, Kaufman Z, Arima Y, Oishi K, Chaves S, Nyawanda B, Al-Jarallah RA, Kuri-Morales PA, Matus CR, Corona MEJ, Burmaa A, Darmaa O, Obtel M, Cherkaoui I, van den Wijngaard CC, van der Hoek W, Baker M, Bandaranayake D, Bissielo A, Huang S, Lopez L, Newbern C, Flem E, Grøneng GM, Hauge S, de Cosío FG, de Moltó Y, Castillo LM, Cabello MA, von Horoch M, Medina Osis J, Machado A, Nunes B, Rodrigues AP, Rodrigues E, Calomfirescu C, Lupulescu E, Popescu R, Popovici O, Bogdanovic D, Kostic M, Lazarevic K, Milosevic Z, Tiodorovic B, Chen M, Cutter J, Lee V, Lin R, Ma S, Cohen AL, Treurnicht F, Kim WJ, Delgado-Sanz C, de mateo Ontañón S, Larrauri A, León IL, Vallejo F, Born R, Junker C, Koch D, Chuang JH, Huang WT, Kuo HW, Tsai YC, Bundhamcharoen K, Chittaganpitch M, Green HK, Pebody R, Goñi N, Chiparelli H, Brammer L, Mustaquim D, Global Seasonal Influenza-associated Mortality Collaborator N. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. The Lancet. 2018;391(10127):1285-300.
  • Huang QS, Bandaranayake D, Wood T, Newbern EC, Seeds R, Ralston J, Waite B, Bissielo A, Prasad N, Todd A, Jelley L, Gunn W, McNicholas A, Metz T, Lawrence S, Collis E, Retter A, Wong SS, Webby R, Bocacao J, Haubrock J, Mackereth G, Turner N, McArdle B, Cameron J, Reynolds G, Baker MG, Grant CC, McArthur C, Roberts S, Trenholme A, Wong C, Taylor S, Thomas P, Duque J, Gross D, Thompson MG, Widdowson MA, team Si. Risk factors and attack rates of seasonal influenza infection: results of the SHIVERS seroepidemiologic cohort study. The Journal of infectious diseases. 2018 Jul 17. PubMed PMID: 30016464.
  • Wilson N, Ferguson C, Rice G, Baker M, Schrader B, Clement C, Thomson G. Remembering the 1918 influenza pandemic: National survey of memorials and scope for enhancing educational value around pandemic preparedness. NZ Med J. 2017; 130: 53-70.
  • Fell DB, Azziz-Baumgartner E, Baker MG, Batra M, Beauté J, Beutels P, Bhat N, Bhutta ZA, Cohen C, De Mucio B, Gessner BD, Gravett MG, Katz MA, Knight M, Lee VJ, Loeb M, Luteijn JM, Marshall H, Nair H, Pottie K, Salam RA, Savitz DA, Serruya SJ, Skidmore B, Ortiz JR, WHO taskforce to evaluate influenza data to inform vaccine impact and economic modelling. Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group. Vaccine. 2017;35:5738-50.
  • Khieu TQ, Pierse N, Telfar-Barnard LF, Zhang J, Huang QS, Baker MG. Modelled seasonal influenza mortality shows marked differences in risk by age, sex, ethnicity and socioeconomic position in New Zealand. Journal of Infection. 2017 Sep 1;75(3):225-33.
  • Davis RE, Dougherty E, McArthur C, Huang QS, Baker MG. Cold, Dry Air is Associated with Influenza and Pneumonia Mortality in Auckland, New Zealand. Infl Other Respiratory Viruses. 2015 Dec 1.
  • Khieu TQT, Pierse N, Telfar Barnard L, Huang QS, Baker MG. Estimating the contribution of influenza to hospitalisations in New Zealand from 1994-2008. Vaccine 2015; 33: 4087-92.
  • Kessaram T, Stanley J, Baker MG. Estimated deaths caused by seasonal influenza in NZ. Influenza Other Respir Viruses 2015; 9: 14-19.
  • MacRae J, Love T, Baker MG, Dowell A, Carnachan M, Stubbe M, McBain L. Identifying influenza-like illness presentation from unstructured general practice clinical narrative using a text classifier rule-based expert system versus a clinical expert. BMC medical informatics and decision making. 2015 Oct 6;15(1):1
  • Huang QS, Turner N, Baker MG, Williamson DA, Wong C, Webby R, Widdowson MA. Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance. Influenza and other respiratory viruses. 2015 Jul 1;9(4):179-90.
  • Wilson N, Summers J, Baker MG. Impact of the 1918–19 influenza pandemic on the New Zealand Military and persisting lessons for pandemic control. Microbiology Australia 2015; 35:138-40.
  • Huang QS, Baker M, McArthur C, Roberts S, Williamson D, Grant C, ... & Widdowson MA. Hospital-based surveillance for severe acute respiratory infections (SARI) caused by influenza and other respiratory pathogens, New Zealand. Western Pacific Surveillance and Response, 2014; 5(2).
  • Summers JA, Stanley J, Baker MG, Wilson N. Risk factors for death from pandemic influenza in 1918-19: A case-control study. Influenza Other Respir Viruses. 2014 Feb 3. doi: 10.1111/irv.12228. [Epub ahead of print].
  • Priest P, Duncan A, Jennings L, Brunton C, Baker MG. Effectiveness of border screening for detecting influenza in arriving airline passengers. Am J Public Health 2013; 103: 1412-18.
  • Jacobs JH, Archer BN, Baker MG, Cowling BJ, Heffernan RT, Mercer G, Uez O, Hanshaoworakul W, Viboud C, Schwartz J, Tchetgen Tchetgen E, Lipsitch M. Searching for sharp drops in the incidence of pandemic A/H1N1 influenza by single year of age. PLoS One. 2012;7(8):e42328. Epub 2012 Aug 2.
  • Summers JA. Pandemic Influenza Outbreak on Troop Ship—Diary of a Soldier in 1918. Emerg Inf Dis 2012;18(11)
  • Wilson N, Telfar Barnard L, Summers JA, Shanks GD, Baker MG. Differential Mortality by ethnicity in 3 influenza pandemics over a century, New Zealand. Emerg Infect Dis 2012;18:71-77
  • Jutel A, Baker MG, Stanley J, Huang GS, Don Bandaranayake. Self-diagnosis of influenza during a pandemic: A cross sectional survey. BMJ Open 2011; 1: e000234.
  • Bandaranayake D, Jacobs M, Baker M, Hunt D, Wood T, Bissielo A, Macfarlane M, Lopez L, Mackereth G, Huang QS. The Second Wave of 2009 Pandemic Influenza A(H1N1) in New Zealand. Euro Surveill 2011 Feb 10;16(6). pii: 19788.
  • Lipsitch M, Finelli L, Heffernan RT, Leung GM, Redd, Baker MG, Biedrzycki PA, Cowling BJ, De Angelis D, Eagle N, Fine AD, Fraser C, Hatchett RJ, Kohl KS, Korch G, Madoff LC, Olson DR, Riley S, Simonsen L, Van Kerkhove MD, van Noort S, Viboud C, Wallinga J, White LF, Widdowson MA. Improving the evidence base for decision making during a pandemic: The Example of 2009 Influenza A/H1N1. Biosecur Bioterror 2011 Jun;9:89-115
  • Summers JA, Wilson N, Baker MG. New research on pandemic influenza at the World Congress of Epidemiology, Edinburgh, 7-11 August 2011. Euro Surveill. 2011;16(45):pii=20011.
  • Duncan AR, Priest PC, Jennings LC, Brunton CR, Baker MG. Screening for influenza infection in international airline travellers. Am J Public Health. 2009; 99 (Suppl 2): S360-2.
  • McLeod M, Kelly H, Wilson N, Baker MG. Border control measures in the influenza pandemic plans of six South Pacific nations: a critical review. N Z Med J 2008;121:62-72.
  • Bandaranayake D, Huang QS, Bissielo A, Wood T, Mackereth G, Baker MG, Beasley R, Reid S, Roberts S, Hope V; on behalf of the 2009 H1N1 serosurvey investigation team. Seroprevalence and risk factors in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS One. 2010 Oct 14;5(10):e13211.
  • Summers JA, Wilson N, Baker MG, Shanks GD. Mortality risk factors for pandemic influenza on New Zealand troop ship, 1918. Emerg Infect Dis 2010;16:1931-1937.
  • Baker MG, Thornley CN, Mills C, Roberts S, Perera S, Peters J, Kelso A, Barr I, Wilson N. Transmission of pandemic A/H1N1 2009 influenza on passenger aircraft: retrospective cohort study. BMJ 2010;340:c2424. Full free text at: http://www.bmj.com/cgi/content/full/340/may21_1/c2424?view=long&pmid=20495017
  • Wilson N, Howden-Chapman P, Baker MG. Co-benefits and 'no regrets' benefits of influenza pandemic planning. Influenza Other Respi Viruses 2010;4(3):113-115
  • Manning S, Barry T, Wilson N, Baker MG. Update: Follow-up study showing post-pandemic decline in hand sanitiser use, New Zealand, December 2009. Euro Surveill 2010;15(3):pii=19466.
  • Duncan AR, Priest PC, Jennings LC, Brunton CR, Baker MG. Screening for influenza infection in international airline travelers. Am J Public Health 2009;99 Suppl 2:S360-2.
  • Wilson N, Mason K, Tobias M, Peacey M, Huang QS, Baker M. Interpreting “Google Flu Trends” data for pandemic H1N1 influenza: The New Zealand experience. Euro Surveill 2009;14(44):pii=19386.
  • Baker MG, Kelly H, Wilson N. Pandemic H1N1 influenza lessons from the southern hemisphere. Euro Surveill2009;14(42):pii=19370.
  • Eichner M, Schwehm M, Wilson N, Baker MG. Small islands and pandemic influenza: Potential benefits and limitations of travel volume reduction as a border control measure. BMC Infect Dis 2009;9:160.
  • Murray R, Chandler C, Clarkson Y, Wilson N, Baker M, Cunningham R, on behalf of the Wellington Respiratory and Hand Hygiene Study Group. Sub-optimal hand sanitiser usage in a hospital entrance during an influenza pandemic, New Zealand, August 2009. Euro Surveill 2009;14(37):pii=19331
  • Wilson N, Summers J, Baker M, Rice G. A bizarre case of drowning as a result of pandemic influenza (1918 pandemic). NZ Med J 2009;122(1302): 9-94.
  • Baker MG, Wilson N, Huang QS, Paine S, Lopez L, Bandaranayake D, Tobias M, Mason K, Mackereth GF, Jacobs M, Thornley C, Roberts S, McArthur C. Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. Euro Surveill 2009;14(34):pii=19319
  • Nishiura H, Wilson N, Baker MG. Estimating the reproduction number of the novel influenza A virus (H1N1) in a Southern Hemisphere setting: preliminary estimate in New Zealand. NZ Med J 2009;122(1299):73-77.
  • Wilson N, Baker MG. The emerging influenza pandemic: estimating the case fatality ratio. Euro Surveill. 2009;14(26):pii=19255.
  • Nishiura H, Wilson N. Transmission dynamics of the 1918 influenza pandemic in New Zealand: analyses of national and city data. NZ Med J 2009;122(1296):81-85.
  • Schwehm M, Eichner M, Wilson N, Baker MG. A freely available software tool for assessing aspects of pandemic influenza risk reduction for small islands. NZ Med J 2009 122(1295):94-95.
  • Nishiura H, Wilson N, Baker MG. Quarantine for pandemic influenza control at the borders of small island nations. BMC Infect Dis 2009, 9:27. (11 March 2009) [Abstract] [Provisional PDF].
  • Schwehm M, Wilson N. Potential impact of pandemic influenza interventions in New Zealand: a brief modelling study. NZ Med J 2009;122(1291):117-121.
  • Wilson N, Baker M. Comparison of the content of the New Zealand influenza pandemic plan with European pandemic plans. NZ Med J 2009;122:36-46.
  • Wilson N, Baker MG, Jennings LC. The clioepidemiology of pandemic influenza and next steps for pandemic influenza research in New Zealand. NZ Med J 2008;121:(1284):6-10.
  • McLeod M, Kelly H, Wilson N, Baker M. A critical review of border control measures in the influenza pandemic plans of six South Pacific Nations. NZ Med J 2008;121:62-72.
  • McLeod MA, Baker M, Wilson N, Kelly H, Kiedrzynski T, Kool JL. Protective Effect of Maritime Quarantine in South Pacific Jurisdictions, 1918-19 Influenza Pandemic. Emerg Infect Dis 2008;14:468-470.
  • McSweeny K, Colman A, Fancourt N, Parnell M, Stantiall S, Rice G, Baker M, Wilson N. Was rurality protective in the 1918 influenza pandemic in New Zealand? NZ Med J 2007;120:U2579.
  • Roberts MG, Baker M, Jennings LC, Sertsou G, Wilson N. A model for the spread and control of pandemic influenza in an isolated geographical region. J R Soc Interface 2007;4:325-330.
  • Sertsou G, Wilson N, Baker M, Nelson P, Roberts MG. Key transmission parameters of an institutional outbreak during the 1918 influenza pandemic estimated by mathematical modeling. Theor Biol Med Model2006;3:38.
  • Wilson N, Rice G, Thomson G, Baker M. Re-evaluating a local public health control measure used for pandemic influenza in 1918. NZ Med J 2005;118:U1714.
  • Wilson N, Baker M, Crampton P, Mansoor O. The potential impact of the next influenza pandemic on a national primary care medical workforce. Hum Resour Health 2005;3:7.
  • Wilson N, Mansoor O, Baker M. Estimating the impact of the next influenza pandemic on population health and health sector capacity in New Zealand. NZ Med J 2005;118:U1346.
  • Wilson N, Mansoor O, Lush D, Kiedrzynski T. Modeling the impact of pandemic influenza on Pacific Islands.Emerg Infect Dis 2005;11:347-349.

Tuberculosis

  • Baker M, Das D, Venugopal K, Howden-Chapman P. Tuberculosis associated with household crowding in a developed country. J Epidemiol Community Health 2008; 62; 715-21.
  • Das D, Baker M, Venugopal K, McAllister S. Why the tuberculosis incidence rate is not falling in New Zealand? NZ Med J 2006; 119: U2248.
  • Das D, Baker M, Calder L. Tuberculosis epidemiology in New Zealand: 1995 – 2004. NZ Med J 2006; 119: U2249.

Vector borne diseases (including arboviruses)

  • Snell A, Wilson N. Can schools contribute to mosquito surveillance?: A New Zealand pilot study. N Z Med J 2006;119:U1857.
  • Khan R, Lopez L, Baker M. Rise in imported dengue fever in New Zealand. N Z Public Health Rep 2001; 9: 81-4.

Imported infections / disease control at borders

  • Boyd M, Mansoor OD, Baker MG, Wilson N. Economic evaluation of border closure for a generic severe pandemic threat using New Zealand Treasury methods. Aust N Z J Public Health. 2018 Oct;42(5):444-6. PubMed PMID: 30088691.
  • Boyd M, Baker MG, Mansoor OD, Kvizhinadze G, Wilson N. Protecting an island nation from extreme pandemic threats: Proof-of-concept around border closure as an intervention. PloS One. 2017 Jun 16;12(6):e0178732.
  • Jennings L, Priest PC, Psutka RA, Duncan AR, Anderson T, Mahagamasekera P, Strathdee A, Baker MG. Respiratory Viruses in Airline Travellers with Influenza Symptoms: Results of an Airport Screening Study. J Clin Virol 2015;67:8-13.
  • Priest P, Duncan A, Jennings L, Brunton C, Baker MG. Effectiveness of border screening for detecting influenza in arriving airline passengers. Am J Public Health 2013; 103: 1412-18.
  • Hale MJ, Hoskins RS, Baker MG. Screening for influenza A(H1N1)pdm09, Auckland International Airport, New Zealand. Emerg Infect Dis 2012 May;18(5):866-8. http://dx.doi.org/10.3201/eid1805.111080.
  • Duncan AR, Priest PC, Jennings LC, Brunton CR, Baker MG. Screening for influenza infection in international airline travellers. Am J Public Health. 2009; 99 (Suppl 2): S360-2.
  • McLeod M, Kelly H, Wilson N, Baker MG. Border control measures in the influenza pandemic plans of six South Pacific nations: a critical review. N Z Med J 2008;121:62-72.
  • Baker MG, Thornley CN, Mills C, Roberts S, Perera S, Peters J, Kelso A, Barr I, Wilson N. Transmission of pandemic A/H1N1 2009 influenza on passenger aircraft: retrospective cohort study. BMJ 2010;340:c2424. Full free text at: http://www.bmj.com/cgi/content/full/340/may21_1/c2424?view=long&pmid=20495017
  • Duncan AR, Priest PC, Jennings LC, Brunton CR, Baker MG. Screening for influenza infection in international airline travelers. Am J Public Health 2009;99 Suppl 2:S360-2.
  • Eichner M, Schwehm M, Wilson N, Baker MG. Small islands and pandemic influenza: Potential benefits and limitations of travel volume reduction as a border control measure. BMC Infect Dis 2009;9:160.
  • Schwehm M, Eichner M, Wilson N, Baker MG. A freely available software tool for assessing aspects of pandemic influenza risk reduction for small islands. NZ Med J 2009 122(1295):94-95.
  • Nishiura H, Wilson N, Baker MG. Quarantine for pandemic influenza control at the borders of small island nations. BMC Infect Dis 2009, 9:27. (11 March 2009) [Abstract] [Provisional PDF].
  • McLeod M, Kelly H, Wilson N, Baker M. A critical review of border control measures in the influenza pandemic plans of six South Pacific Nations. NZ Med J 2008;121:62-72.
  • McLeod MA, Baker M, Wilson N, Kelly H, Kiedrzynski T, Kool JL. Protective Effect of Maritime Quarantine in South Pacific Jurisdictions, 1918-19 Influenza Pandemic. Emerg Infect Dis 2008;14:468-470.

Antimicrobial resistance

  • Metcalfe S, Baker MG, Freeman J, Wilson N, Murray P. Combating antimicrobial resistance demands nationwide action and global governance [Editorial]. N Z Med J 2016;129(1444):8-14. http://www.nzma.org.nz/__data/assets/pdf_file/0010/51958/Metcalfe-FINAL.pdf
  • Williamson D, Baker M, French N, Thomas M. Missing in action: an antimicrobial resistance strategy for New Zealand. NZMJ 2015, 128; No 1427.


Vaccine preventable diseases and vaccine effectiveness

  • Pierse N, Kelly H, Thompson MG, Bissielo A, Radke S, Huang QS, Baker MG, Turner N. Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014. Vaccine. 2016 Jan 20;34(4):503-9..
  • Turner N, Pierse N, Bissielo A, Huang QS, Radk S, Baker MG, Widdowson M, Kelly H, SHIVERS investigation team. Effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand in 2013. Euro Surv 2014, 19(34).
  • Turner N, Pierse N, Bissielo A, Huang QS, Baker MG, Widdowson M, Kelly H. The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012. 2014, Vaccine, 32(29), 3687-3693.
  • Rose SB, Lawton BA, Lanumata TS, Hibma M, Baker MG. Predictors of intent to vaccinate against HPV/cervical cancer: a multi-ethnic survey of 769 parents in New Zealand. N Z Med J. 2012;125: 51-62.
  • Huang QS, Greening G, Baker M, Grimwood K, Hewitt J, Hulston D, Duin LV, Fitzsimons A, Garrett N, Lennon D, Shimizu H, Miyamura T, Pallansch MA. Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand. Lancet 2005; 366: 394-6.
  • Mansoor O, Wilson N. Preventing and treating hepatitis B infection: Immunisation is most important strategy to control hepatitis B. BMJ 2005;330:197-198.

Housing, crowding and infectious diseases

  • Bennett J, Howden-Chapman P, Chisholm E, Keall M, Baker MG. Towards an agreed quality standard for rental housing: Field testing of a New Zealand housing WOF tool. ANZJPH 2016 Mar 1.
  • Baker MG, Zhang J, Blakely T, Crane J, Saville-Smith K, Howden-Chapman P. Collaborating with a social housing provider supports a large cohort study of the health effects of housing conditions. BMC public health. 2016 Feb 16;16(1):1.
  • Kelly A, Denning-Kemp G, Geiringer K, Abdulhamid A, Albabtain A, Beard M, Brimble J, Campbell A, Feng S, Haminudin M, Hunter J, Kunac N, Lin P, Lundon N, Waclawczyk A, Richter JC, Keall M, Howden-Chapman P, Baker MG. Health service factors in children admitted to Wellington Hospital. NZ Med J 2014, Accepted.
  • Baker M, Zhang J, Howden-Chapman P. The health effects of social housing: Results of the Social Housing Outcomes Worth (SHOW) study. In: Homes people can afford: How to improve housing in New Zealand. Edited by Sara Bierre, Philippa Howden-Chapman and Lisa Early. Wellington; Steele Roberts Aotearoa, 2013
  • Baker MG, McDonald A, Zhang J, Howden-Chapman P. Infectious diseases attributable to household crowding in New Zealand: A systematic review and burden of disease estimate. Wellington: He Kainga Oranga/ Housing and Health Research Programme, University of Otago, 2013.
  • Baker M, Goodyear R, Telfar Barnard L, Howden-Chapman P. The distribution of household crowding in New Zealand: An analysis based on 1991 to 2006 Census data. Wellington: He Kainga Oranga/ Housing and Health Research Programme, University of Otago, 2012
  • Baker M, Das D, Venugopal K, Howden-Chapman P. Tuberculosis associated with household crowding in a developed country. J Epidemiol Community Health 2008; 62; 715-21.
  • Howden-Chapman P, Baker M. An (indoor) climate for change: Sustainable housing research informs policy. Housing Works 2007; 5: 10-13.
  • Telfar Barnard L, Baker M, Hales S, Howden-Chapman. The role of housing age and socio-economic status in New Zealand excess winter hospitalisation patterns. 5th Warwick healthy housing conference, Warwick, 17-19 March 2008.
  • Baker M, Turner R, Blakely T, Howden-Chapman P. Reducing Household Crowding in New Zealand to Control Infectious Diseases. Proceedings of the 2nd WHO International Housing and Health Symposium, Vilnius, 2004: 267-75
  • Baker M, McNicholas A, Garrett N, Jones N, Stewart J, Koberstein V, Lennon D. Household crowding a major risk factor for epidemic meningococcal disease in Auckland children. Paed Infect Dis J 2000; 19: 983-90.

Other infectious disease topics

  • Rose SB, Bromhead C, Lawton BA, Zhang J, Stanley J, Baker MG. Access to chlamydia testing needed for high-risk groups: patterns of testing and detection in an urban area of New Zealand. Aust NZ J Pub Health 2012; 36: 343–50.
  • Wilson N, Baker MG. Celebrating 50 years of polio elimination in New Zealand: But inadequate progress in eliminating other vaccine-preventable diseases. N Z Med J 2012;125(1365):1-8.
  • White P, Pink R, Harte D, Janssen K, Mason K, Ambrose C, Humphrey A, Graham F, Baker MG. Spatial Epidemiological Investigation of Legionellosis Outbreak in Christchurch (April-August 2005): The Value of Spatial Methods for Practical Public Health. Epidemiol Infect. 2012 Jun 15:1-11. [Epub ahead of print].
  • Manning S, Barry T, Baker MG, Wilson N. Hand hygiene practices at a hospital entrance after the 2009 influenza pandemic: observational study over one year. NZ Med J 2011;124(1334):111-114.
  • Barry T, Manning S, Lee MS, Eggleton R, Hampton S, Kaur J, Baker MG, Wilson N. Respiratory hygiene practices by the public during the 2009 influenza pandemic: An observational study. Influenza Other Respi Viruses (E-publication 25 February 2011) [Abstract].
  • Lawton BA, Rose SB, Elley CR, Bromhead C, MacDonald J, Baker MG. Increasing the uptake of opportunistic chlamydia screening in general practice. J Primary Care 2010; 2: 199-207.
  • Rose SB, Lawton BA, Lanumata T, Hibma M, Baker MG. HPV/cervical cancer vaccination: Parental preferences on age, place and information needs. Journal of Primary Health Care 2010; 2: 190-198.
  • Manning S, Barry T, Wilson N, Baker MG. Update: Follow-up study showing post-pandemic decline in hand sanitiser use, New Zealand, December 2009. Euro Surveill. 2010;15(3):pii=19466. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19466
  • Baker MG Ortega-Benito JM, Garret N, Bromhead C, Leslie K, MacDonald J, McNicholas A. Prevalence and risk factors for Chlamydia trachomatis infection in female New Zealand University Students. NZ Med J; 2005, 118: U1607.

Climate change and Seasonality

  • Lal A, Lill AWT, Mcintyre M, Hales S, Baker MG, French NP. Climate variability, Agricultural Land Use and Human Enteric Zoonotic Diseases in New Zealand. ANZJPH, 2014, Accepted.
  • Lal A, Hales S, French N, Baker MG. Seasonality in human zoonotic enteric diseases: a systematic review. PLoS One. 2012;7(4):e31883. Epub 2012 Apr 2.
  • Lal A, Baker MG, French N, Hales S. Potential effects of global environmental changes on cryptosporidiosis and giardiasis transmission. Trends Parasitol 2013 29:83-90. Epub 2012 Dec 5.
  • Christensen AL, Rasmussen LH, Baker MG, Lip GYH, Dethlefsen C, Larsen TB. Seasonal variation and trend in hospital admissions for stroke in patients with atrial fibrillation in Denmark and New Zealand: analysis of hospital discharge data from 1977 to 2008 . BMJ Open. 2012 Aug 24;2(4). doi:pii: e001210. 10.1136/bmjopen-2012-001210.
  • Wilson N, Slaney D, Baker MG, Hales S, Britton E. Climate change and infectious diseases in New Zealand: a brief review and tentative research agenda. Rev Environ Health 2011;26(2):93-99.
  • Wilson N, Slaney D, Baker MG, Hales S. Infectious Diseases and Climate Change in New Zealand: A Brief Review. [Poster presentation 59]. 2010 International Conference on Emerging Infectious Diseases. Atlanta, USA; 11-14 July, 2010.
  • Wilson N, Lush D, Baker MG. Meteorological and climate change themes at the 2010 International Conference on Emerging Infectious Diseases. Euro Surveill 2010;15(30). pii:19627.
  • Hales S, Blakely T, Foster RH, Baker MG, Howden-Chapman P. Seasonal patterns of mortality in relation to social factors. J Epidemiol Community Health 2010 Oct 19. [Epub ahead of print]
  • Britton R, Hales D, Venugopal K, Baker MG. The impact of climate variability and change on cryptosporidiosis and giardiasis rates in New Zealand. J Water Health. 2010; 8: 561-71.
  • Wilson N, Lush D, Baker MG. Meteorological and climate change themes at the 2010 International Conference on Emerging Infectious Diseases. Euro Surveill. 2010; 15: pii=19627.
  • Metcalfe S, Woodward A, Macmillan A, Baker M, Howden-Chapman P, et al. Why New Zealand must rapidly halve its greenhouse gas emissions. NZMJ 2009; 122:1-24.
  • Telfar Barnard L, Baker MG, Hales S, Howden-Chapman P. Excess winter morbidity and mortality: still a lack of evidence that housing or socio-economic status makes much difference. Rev Environ Health 2008; 23: 203-221.
  • Davie GS, Baker MG, Hales S, Carlin J. Trends and determinants of excess winter mortality in New Zealand: 1980 to 2000. BMC Public Health. 2007; 7: 263.
  • Hales S, Baker M, Howden-Chapman P, Menne B, Woodruff R, Woodward A. Implications of global climate change for housing, human settlements and public health. Rev Environ Health 2007; 22: 295-302.
  • Mann S, Baker M, Hales S, Kamalesh V, Telfar Barnard L, Zhang J, et al. Excess winter cardiovascular mortality and morbidity in New Zealand is seen in all disease subcategories. Heart, Lung and Circulation 2009;18(Supplement 2):S21-S22

Environmental health

  • Telfar Barnard L, Baker MG, Hales S, Howden-Chapman P. Novel use of three administrative datasets to establish a cohort for environmental health research. BMC Pub Health, 2015;15: 246.
  • Keall, MD, Pierse N, Howden-Chapman P, Cunningham CW, Cunningham M, Guria J, Baker MG. Reduction in fall injury rates achieved by home modification: a cluster randomised controlled trial. The Lancet 2015;385:231-8.
  • Keall MD, Crane J, Baker MG, Wickens K, Howden-Chapman P, Cunningham M. A measure for quantifying the impact of housing quality on respiratory health: a cross-sectional study. Environ Health. 2012 May 14;11:33
  • Howden-Chapman P, Baker MG, Bierre S. The houses children live in: Policies to improve housing quality. Policy Quarterly 2013; 9: 35-9.
  • Keall MD, Ormandy D, Baker MG. Injuries associated with housing conditions in Europe: a burden of disease study based on 2004 injury data. Environmental Health 2011, 10: 98.
  • Wilson N, Parry R, Jalali J, Jalali R, McLean L, McKay O. High air pollution levels in some takeaway food outlets and barbecue restaurants: pilot study in Wellington City, New Zealand. N Z Med J 2011;124(1330):81-86.
  • Keall M, Baker MG, Howden-Chapman P, Cunningham M, Ormandy D. Assessing housing quality and its impact on health, safety and sustainability. J Epidemiol Comm Health 2010; 64: 765-71.
  • Gillespie-Bennett J, Pierse N, Wickens K, Crane J, Nicholls S, Shields D, Boulic M, Viggers H, Baker M, Woodward A, Howden-Chapman P; Housing, Heating, and Health Team. Sources of nitrogen dioxide (NO2) in New Zealand homes. Finding from a community randomized controlled trial of heater substitutions. Indoor Air 2008; 18: 521-8.
  • Wilson N, Horrocks J. Lessons from the removal of lead from gasoline for controlling other environmental pollutants: A case study from New Zealand. Environ Health 2008;7:1. (Found at: http://www.ehjournal.net/content/7/1/1)
  • Horrocks J, Wilson N. NGO power versus leaded petrol in New Zealand. International Journal of Environmental, Cultural, Economic and Social Sustainability 2008;4(5):19-28. (Found at: http://ijs.cgpublisher.com/product/pub.41/prod.435)

Disease surveillance

  • Baker MG, Easther S, Wilson N. A surveillance sector review applied to infectious diseases at a country level. BMC Public Health 2010;10:332.
  • Wilson N, Mason K, Tobias M, Peacey M, Huang QS, Baker M. Interpreting “Google Flu Trends” data for pandemic H1N1 influenza: The New Zealand experience. Euro Surveill. 2009;14(44):pii=19386.
  • Wilson N, Baker M, Shaw C. “One ticket to town and just letting you know I have syphilis.” Time to replace the Health Act 1956? N Z Med J 2008;121(1287):95.
  • Baker M, Mansoor O, Wilson N, MacDonald J. Modern surveillance needed to control the increase in STIs. N Z Med J 2005;118:U1394.

International control measures (eg IHR 2005)

  • Baker M. The new international health regulations: Their relevance to One World One Health and the response to influenza A(H1N1). In Proceedings of the Food Safety, Animal Welfare & Biosecurity Branch of the NZVA Annual Conference, Rotorua, 24-27 June 2009. VetLearn, Palmerston North, 2009: 113-7.
  • Baker M, Forsyth A. The new International Health Regulations: A revolutionary change in global health security. NZ Med J 2007; 120: U 2872.
  • Baker MG, Fidler DP. Global public health surveillance under the new International Health Regulations. Emerg Infect Dis 2006: 12: 1058-65.